Valuation: Star Scientific, Inc.

Market Cap 153K 136K 127K 116K 219K 14.77M 222K 1.54M 597K 7.52M 576K 563K 24.16M P/E 2014
-0.87x
P/E 2015 -1.04x
Enterprise Value 20.01M 17.77M 16.62M 15.15M 28.52M 1.93B 28.91M 201M 77.84M 981M 75.13M 73.5M 3.15B EV / Sales 2014
-
EV / Sales 2015 -
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.32%-2.32%+39.87%+114.47% 1,031B
-2.09%-4.02%+39.65%+67.46% 638B
-0.48%-1.75%+6.59%+75.70% 462B
-1.28%-2.82%+59.55%+40.22% 359B
-0.03%-3.96%+23.63%+40.70% 335B
-1.58%-0.76%+13.50%+26.44% 273B
-2.02%-2.97%-3.25%+9.88% 253B
-2.63%+1.26%+37.74%+54.39% 228B
-1.15%-1.26%+32.97%+99.46% 185B
Average -1.29%-0.36%+27.80%+58.75% 418.21B
Weighted average by Cap. -1.09%-0.35%+30.89%+70.31%

Financials

2014 2015
Net sales - -
Net income -38.52M -34.21M -31.99M -29.15M -54.89M -3.71B -55.64M -387M -150M -1.89B -145M -141M -6.07B -6.84M -6.08M -5.69M -5.18M -9.75M -659M -9.89M -68.78M -26.63M -336M -25.7M -25.14M -1.08B
Net Debt -45K -39.97K -37.38K -34.06K -64.13K -4.33M -65.01K -452K -175K -2.21M -169K -165K -7.09M 19.86M 17.64M 16.49M 15.03M 28.3M 1.91B 28.69M 200M 77.24M 974M 74.55M 72.94M 3.13B
Logo Star Scientific, Inc.
Rock Creek Pharmaceuticals Inc is a United States-based pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine.
Employees
-